Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Seth Klarman, latest 13F

Seth Klarman · Q2 2016

Baupost Group

Portfolio at the end of Q2 2016, from the 13F filed August 12, 2016. See the filing on EDGAR ↗

CompanyWeightValueSharesPriceHeld sinceChange
EMC EMC · history 21.0% $1.55B 56,961,725 $27.17 Q4 2015 Add 10%
Cheniere Energy LNG · history 15.2% $1.12B 29,841,174 $37.55 Q1 2014 No change
Viasat VSAT · history 11.2% $823.5M 11,533,137 $71.40 Q2 2013 or earlier No change
Allergan AGN · history 6.3% $462.6M 2,001,978 $231.09 Q1 2016 Add 16%
Antero Resources AR · history 5.1% $376.9M 14,505,881 $25.98 Q3 2014 Reduce 33%
Olin OLN · history 3.6% $266.8M 10,739,202 $24.84 Q3 2015 No change
PBF Energy PBF · history 3.4% $253.0M 10,641,175 $23.78 Q3 2013 No change
Citigroup C · history 3.0% $219.0M 5,167,000 $42.39 Q2 2016 Buy
Twenty-First Century Fox FOXA · history 2.8% $208.2M 7,696,922 $27.05 Q3 2015 No change
PayPal PYPL · history 2.8% $206.8M 5,664,087 $36.51 Q3 2015 Reduce 20%
Twenty-First Century Fox FOX · history 2.7% $198.3M 7,278,100 $27.25 Q3 2015 No change
Innoviva INVA · history 2.5% $185.4M 17,610,091 $10.53 Q2 2013 or earlier Reduce 11%
Keryx Biopharmaceuticals KERX · history 2.3% $170.7M 25,791,678 $6.62 Q1 2014 No change
Theravance Biopharma TBPH · history 2.3% $166.8M 7,350,991 $22.69 Q2 2014 Add 13%
VMware VMW · history 1.7% $128.9M 2,252,694 $57.22 Q1 2016 No change
Atara Biotherapeutics ATRA · history 1.6% $120.6M 5,359,632 $22.51 Q4 2014 No change
Veritiv VRTV · history 1.6% $114.4M 3,044,385 $37.58 Q3 2014 No change
Forward Pharma FWP · history 1.3% $97.5M 5,367,300 $18.17 Q4 2014 No change
Qurate Retail QVCA · history 1.2% $91.5M 2,469,533 $37.07 Q2 2016 Buy
ChipMOS IMOS · history 0.9% $67.9M 3,751,853 $18.11 Q2 2013 or earlier No change
KLX KLXI · history 0.8% $62.0M 2,000,000 $31.00 Q1 2015 No change
Novagold Resources NG · history 0.8% $58.1M 9,500,000 $6.12 Q2 2013 or earlier Reduce 37%
Avis Budget Group CAR · history 0.8% $57.6M 1,787,227 $32.23 Q2 2016 Buy
SunEdison Semiconductor SEMI · history 0.7% $49.7M 8,372,979 $5.93 Q2 2014 No change
American International Group AIG.WS · warrants · history 0.6% $47.7M 2,550,917 $18.69 Q2 2013 or earlier Add 20%
Atlanta Braves Holdings BATRK · history 0.6% $43.9M 2,994,010 $14.66 Q2 2016 Buy
Innoviva INVA.CV · convertible notes · history 0.5% $38.9M 48,230,000 prn Q3 2014 No change
Silver Run Acquisition SRAQ · history 0.5% $36.8M 3,750,000 $9.80 Q2 2016 Buy
Paratek Pharmaceuticals PRTK · history 0.4% $28.4M 2,044,498 $13.91 Q4 2014 Add 32%
Cascadian Therapeutics CASC · history 0.3% $23.6M 25,000,000 $0.94 Q2 2016 Buy
Credit Acceptance CACC · history 0.3% $18.5M 100,000 $185.08 Q2 2016 Buy
Sunrun RUN · history 0.2% $16.9M 2,848,082 $5.93 Q3 2015 No change
Sculptor Capital OZM · history 0.2% $12.8M 3,373,891 $3.80 Q2 2016 Buy
Atlanta Braves Holdings BATRA · history 0.2% $12.0M 800,000 $15.04 Q2 2016 Buy
Kindred Biosciences KIN · history 0.1% $10.7M 3,013,848 $3.54 Q4 2013 No change
Orexigen Therapeutics OREX · history 0.1% $9.6M 22,268,399 $0.43 Q3 2015 No change
Citigroup C.WS · warrants · history 0.1% $6.0M 102,553,207 $0.06 Q2 2013 or earlier No change
Trilogy Metals TMQ · history 0.1% $5.3M 10,600,758 $0.50 Q2 2013 or earlier No change
Silver Run Acquisition SRAQ.WS · warrants · history 0.0% $1.4M 1,250,000 $1.14 Q2 2016 Buy
39 positions100.0%$7.37B

Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q1 2016, adjusted for stock splits.

Sector weighting

Sector weights in this 13F
Technology24.4%
Energy23.8%
Health care17.8%
Media & telecom17.5%
Financials & real estate7.5%
Materials4.5%
Industrials2.6%
Consumer discretionary1.2%
Other0.8%

What changed from Q1 2016

← Q1 2016 Q3 2016 →